H1B Report
Side-by-side comparison

Deloitte Consulting LLP vs New York Genome Center, Inc.

A direct H-1B sponsorship comparison built from the same DOL Labor Condition Application data that drives every page on H1B Report. Total filings, outcome rates, top occupations and yearly demand side-by-side.

Entity A
Deloitte Consulting LLP
PARank #4FEIN 06-1454513
Entity B
New York Genome Center, Inc.
NYRank #FEIN 80-0631734

Key metrics

All percentages are share of total LCAs filed by each sponsor.

MetricDeloitte Consulting LLPNew York Genome Center, Inc.
Total filings80,813127
Certified %98.23%92.13%
Denied %1.09%0.79%
Withdrawn %0.61%1.57%
Cert-withdrawn %0.07%5.51%
Rank#4
Active yearsFY2010–FY2026FY2012–FY2026
Worksite statePANY

Outcomes — Deloitte Consulting LLP

DOL case-status mix.

Outcome breakdown: Certified 98.2%, Cert-withdrawn 0.1%, Withdrawn 0.6%, Denied 1.1%
Outcome breakdown
OutcomeShare
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%
Certified98.2%
Cert-withdrawn0.1%
Withdrawn0.6%
Denied1.1%

Outcomes — New York Genome Center, Inc.

DOL case-status mix.

Outcome breakdown: Certified 92.1%, Cert-withdrawn 5.5%, Withdrawn 1.6%, Denied 0.8%
Outcome breakdown
OutcomeShare
Certified92.1%
Cert-withdrawn5.5%
Withdrawn1.6%
Denied0.8%
Certified92.1%
Cert-withdrawn5.5%
Withdrawn1.6%
Denied0.8%

Yearly filing volume

Year-over-year H-1B demand for each sponsor.

Deloitte Consulting LLP
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20102,375
FY20113,610
FY20124,716
FY20136,082
FY20147,007
FY20157,572
FY20167,629
FY20177,147
FY201816,089
FY20197,754
FY202052
FY202135
FY202211
FY20231,134
FY20242,702
FY20254,286
FY20262,612
New York Genome Center, Inc.
Time series: 17 points from FY2010 to FY2026
Time series
PeriodValue
FY20100
FY20110
FY20121
FY20134
FY201418
FY201516
FY201617
FY20179
FY201811
FY201910
FY20200
FY20213
FY20226
FY20232
FY20244
FY202517
FY20269

Top 5 occupations — Deloitte Consulting LLP

Top 5 occupations — New York Genome Center, Inc.

Swap an entity
Replace either sponsor above without losing the comparison. 2-way for now; 3+ comparison coming soon.